S
Saint-Louis Hospital | Infectious and Tropical Diseases Service
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KRT-232
Ritonavir
Capecitabine
CTX
methotrexate
177Lu-PSMA-617
Tenofovir
Pembrolizumab
Maraviroc
Neratinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 35 total trials
This study evaluates TL-895, a potent, orally available and highly selective irreversible tyrosine kinase inhibitor combined with navtemadlin (KRT-23...
Active, not recruiting
Acute Myeloid Leukemia
Drug: TL-895
Drug: KRT-232
Trial sponsors
A
T
C
G
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems